1. Home
  2. UA vs HROW Comparison

UA vs HROW Comparison

Compare UA & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Under Armour Inc. Class C

UA

Under Armour Inc. Class C

HOLD

Current Price

$5.95

Market Cap

3.4B

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$34.37

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UA
HROW
Founded
1996
1998
Country
United States
United States
Employees
14400
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
1.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
UA
HROW
Price
$5.95
$34.37
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$71.14
AVG Volume (30 Days)
2.5M
953.3K
Earning Date
02-06-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$32.90
Revenue Next Year
$1.72
$48.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.95
$20.85
52 Week High
$7.91
$54.98

Technical Indicators

Market Signals
Indicator
UA
HROW
Relative Strength Index (RSI) 36.67 30.04
Support Level $5.88 $30.55
Resistance Level $6.44 $40.64
Average True Range (ATR) 0.27 2.21
MACD -0.13 -0.67
Stochastic Oscillator 11.87 3.81

Price Performance

Historical Comparison
UA
HROW

About UA Under Armour Inc. Class C

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and Latin America. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through wholesale partners, company-owned digital channels, and approximately 450 company-owned outlet and full-price stores. The Baltimore-based firm was founded in 1996 and is led by controlling shareholder Kevin Plank.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: